By Frank Prenesti
Date: Thursday 05 Nov 2026
(Sharecast News) - FTSE 250 (MCX) 25,087.11 0.69%
Hikma Pharmaceuticals slid as the drug maker trimmed revenue guidance for its injectables division, offsetting a more upbeat outlook for its branded business.
Morgan Sindall jumped as it said full-year 2026 results were set to be...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news